Clinical trials: Hepatitis C Recurrent
Hepatitis C, Hepatitis C Relapse
Direct Acting Agents in Hepatitis C Patients
This study is a retrospective study conducted at 36 sites. Planned target patient number is 1000.
- Conditions
- Hepatitis C, Hepatitis C Relapse, Hepatitis C Recurrent
- Trial name
- HEPCTURKEY (NCT03145844)
- Where
- Turkey (Türkiye)
- Volunteers
- 2,700 people
- Sponsor
- Fehmi Tabak
Hepatitis C Recurrent, HIV-1-infection
Self-testing for HCV Re-infection in MSM
HIV+MSM (men who have sex with men) that have been cured of a hepatitis C viral infection (HCV) are at risk for HCV re-infection (5-10% per year).
- Trial name
- SELFIE (NCT04004299)
- Testing
- HCV RNA self-test
- Where
- 7 sites in Netherlands
- Volunteers
- 200 people
- Sponsor
- Erasmus Medical Center
Hepatitis C Virus Infection, Hepatitis C Virus Infection, Response to Therapy of
HCV Reinfection in HD Patients Achieving SVR
Among the hemodialysis units, the global incidence of HCV infection ranges from 1.2% to 2.9%. Data regarding the long-term risk of reinfection among hemodialysis patients achieving SVR are limited.
- Conditions
- Hepatitis C Virus Infection, Hepatitis C Virus Infection, Response to Therapy of, Hemodialysis Complication
- Trial name
- NCT04732832
- Where
- 7 sites in Taiwan
- Volunteers
- 350 people
- Sponsor
- National Taiwan University Hospital